DUBLIN--(BUSINESS WIRE)--The "US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to ResearchAndMarkets.com's offering.
The US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016. The market growth can be attributed to the low cost of these drugs as compared to their branded counterparts.
Over the next few years, the market is expected to be driven by a number of favourable factors. The cases of chronic diseases have been increasing on account of ageing population, sedentary lifestyles and poor eating habits. This has resulted in a heightened demand for generic injectables. Furthermore, the drug shortages in the country coupled with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Additionally, the patent expiry of a large number of branded injectable drugs is expected to support the market growth.
The report has segmented the market on the basis of therapeutic area and covers oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular diseases, etc. Among these, oncology generic injectables represent the largest segment. The report has further analysed the various containers used for generic injectables including vials, premix, prefilled syringes and ampoules. On the basis of distribution channels, the report finds that hospitals dominate the market, accounting for the majority of the share.
- Henry Shein Inc.
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global Generic Drug Industry
6 US Generic Drug Industry
7 US Generic Drug Industry - Drug Delivery Systems
8 Global Generic Injectables Industry
9 US Generic Injectables Industry
10 Market by Therapeutic Area
11 Market by Containers
12 Market by Distribution Channel
13 US Generic Injectable Market: Competitive Landscape
14 Generic Injectables Manufacturing Process
15 Project Details, Requirements and Costs Involved
16 Key Players Profiles
For more information about this report visit https://www.researchandmarkets.com/research/f8tkzd/us_generic?w=4